Pamela L Lutsey1, Christina M Parrinello2, Jeffrey R Misialek3, Andy N Hoofnagle4, Clark M Henderson4, Thomas J Laha4, Erin D Michos5,6, John H Eckfeldt7, Elizabeth Selvin6. 1. Division of Epidemiology and Community Health, University of Minnesota School of Public Health, Minneapolis, MN; Lutsey@umn.edu. 2. Department of Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, NY. 3. Division of Epidemiology and Community Health, University of Minnesota School of Public Health, Minneapolis, MN. 4. Department of Laboratory Medicine, University of Washington, Seattle, WA. 5. Division of Cardiology, Johns Hopkins University, Baltimore, MD. 6. Department of Epidemiology and the Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. 7. Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN.
Abstract
BACKGROUND: Quantifying the variability of biomarkers is important, as high within-person variability can lead to misclassification of individuals. Short-term variability of important markers of vitamin D metabolism is relatively unknown. METHODS: A repeatability study was conducted in 160 Atherosclerosis Risk in Communities study participants (60% female, 28% black, mean age 76 years). Fasting serum was drawn at 2 time points, a median of 6 (range 3-13) weeks apart. Vitamin D binding protein (VDBP) and 25-hydroxyvitamin D [25(OH)D] were measured by LC-MS, fibroblast growth factor (FGF23) and parathyroid hormone (PTH) by enzyme-linked immunoassay, and calcium and phosphorus by Roche Cobas 6000. Free and bioavailable 25(OH)D were calculated. We calculated the within-person CV (CVW), intraclass correlation coefficient (ICC), Spearman rank correlation coefficient (r), and percent reclassified. RESULTS: The CVW was lowest for calcium (2.0%), albumin (3.6%), 25(OH)D (6.9%), VDBP (7.0%) and phosphorus (7.6%); intermediate for free 25(OH)D (9.0%) and bioavailable 25(OH)D (9.9%); and highest for PTH (16.7%) and FGF23 (17.8%). Reclassification was highest for PTH, VDBP, and phosphorus (all 7.5%). The ICC and r were highest (≥0.80) for 25(OH)D, free 25(OH)D, bioavailable 25(OH)D and PTH, but somewhat lower (approximately 0.60-0.75) for the other biomarkers. CONCLUSIONS: Six-week short-term variability, as assessed by CVW, was quite low for VDBP, calcium and phosphorus, but fairly high for FGF23 and PTH. As such, multiple measurements of FGF23 and PTH may be needed to minimize misclassification. These results provide insight into the extent of potential misclassification of vitamin D markers in research and clinical settings.
BACKGROUND: Quantifying the variability of biomarkers is important, as high within-person variability can lead to misclassification of individuals. Short-term variability of important markers of vitamin D metabolism is relatively unknown. METHODS: A repeatability study was conducted in 160 Atherosclerosis Risk in Communities study participants (60% female, 28% black, mean age 76 years). Fasting serum was drawn at 2 time points, a median of 6 (range 3-13) weeks apart. Vitamin D binding protein (VDBP) and 25-hydroxyvitamin D [25(OH)D] were measured by LC-MS, fibroblast growth factor (FGF23) and parathyroid hormone (PTH) by enzyme-linked immunoassay, and calcium and phosphorus by Roche Cobas 6000. Free and bioavailable 25(OH)D were calculated. We calculated the within-person CV (CVW), intraclass correlation coefficient (ICC), Spearman rank correlation coefficient (r), and percent reclassified. RESULTS: The CVW was lowest for calcium (2.0%), albumin (3.6%), 25(OH)D (6.9%), VDBP (7.0%) and phosphorus (7.6%); intermediate for free 25(OH)D (9.0%) and bioavailable 25(OH)D (9.9%); and highest for PTH (16.7%) and FGF23 (17.8%). Reclassification was highest for PTH, VDBP, and phosphorus (all 7.5%). The ICC and r were highest (≥0.80) for 25(OH)D, free 25(OH)D, bioavailable 25(OH)D and PTH, but somewhat lower (approximately 0.60-0.75) for the other biomarkers. CONCLUSIONS: Six-week short-term variability, as assessed by CVW, was quite low for VDBP, calcium and phosphorus, but fairly high for FGF23 and PTH. As such, multiple measurements of FGF23 and PTH may be needed to minimize misclassification. These results provide insight into the extent of potential misclassification of vitamin D markers in research and clinical settings.
Authors: Marc G Vervloet; Frans J van Ittersum; Rahel M Büttler; Annemieke C Heijboer; Marinus A Blankenstein; Piet M ter Wee Journal: Clin J Am Soc Nephrol Date: 2010-10-28 Impact factor: 8.237
Authors: C T Sempos; R A Durazo-Arvizu; N Binkley; J Jones; J M Merkel; G D Carter Journal: J Steroid Biochem Mol Biol Date: 2015-08-28 Impact factor: 4.292
Authors: Christina M Parrinello; Pamela L Lutsey; David Couper; John H Eckfeldt; Michael W Steffes; Josef Coresh; Elizabeth Selvin Journal: Clin Chem Date: 2015-10-26 Impact factor: 8.327
Authors: Anastassios G Pittas; Bess Dawson-Hughes; Patricia R Sheehan; Clifford J Rosen; James H Ware; William C Knowler; Myrlene A Staten Journal: Diabetes Care Date: 2014-09-09 Impact factor: 19.112
Authors: Cassianne Robinson-Cohen; Leila R Zelnick; Andrew N Hoofnagle; Pamela L Lutsey; Gregory Burke; Erin D Michos; Steven J C Shea; Russell Tracy; David S Siscovick; Bruce Psaty; Bryan Kestenbaum; Ian H de Boer Journal: J Clin Endocrinol Metab Date: 2017-08-01 Impact factor: 5.958
Authors: Catherine Troja; Andrew N Hoofnagle; Adam Szpiro; Joshua E Stern; John Lin; Rachel L Winer Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-04-21 Impact factor: 4.254
Authors: Michela Bottani; Giuseppe Banfi; Elena Guerra; Massimo Locatelli; Aasne K Aarsand; Abdurrahman Coşkun; Jorge Díaz-Garzón; Pilar Fernandez-Calle; Sverre Sandberg; Ferruccio Ceriotti; Elisabet González-Lao; Margarita Simon; Anna Carobene Journal: Ann Transl Med Date: 2020-07
Authors: Charles Ginsberg; Andrew N Hoofnagle; Ronit Katz; Jessica O Becker; Stephen B Kritchevsky; Michael G Shlipak; Mark J Sarnak; Joachim H Ix Journal: Clin Chem Date: 2021-01-30 Impact factor: 8.327
Authors: Etienne Cavalier; Callum G Fraser; Harjit P Bhattoa; Annemieke C Heijboer; Konstantinos Makris; Candice Z Ulmer; Hubert W Vesper; Samuel Vasikaran; Pierre Lukas; Pierre Delanaye; Anna Carobene Journal: Nutrients Date: 2021-01-28 Impact factor: 5.717
Authors: Sabina Cauci; Marco Viganò; Laura de Girolamo; Paola De Luca; Carlotta Perucca Orfei; Giuseppe Banfi; Giovanni Lombardi; Marco Brayda-Bruno; Alessandra Colombini Journal: Int J Mol Sci Date: 2017-09-29 Impact factor: 5.923